Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Neurobehavioral Changes With GLP-1 (Glucagon-like Peptide-1) Discontinuation

NCT07387796 is registered in ClinicalTrials.gov with The University of Texas at Dallas as lead sponsor.

NCT NCT07387796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07387796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Neurobehavioral Changes With GLP-1 (Glucagon-like Peptide-1) Discontinuation
Lead sponsor
The University of Texas at Dallas
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2026
Completion date
February 28, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug discontinuation, eating behavior changes, substance use disorders, tirzepatide